Last reviewed · How we verify
NCT06246279
Disease Management in Adolescents With Type 1 Diabetes
NA trial testing Adaptation to Adolescence and Type 1 Diabetes Management Training Program in type1diabetes in 58 participants. Completed in 30 April 2024.
30 April 2024
Quick facts
| Lead sponsor | Akdeniz University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 58 |
| Start date | 1 April 2022 |
| Primary completion | 30 April 2024 |
| Estimated completion | 30 April 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Adaptation to Adolescence and Type 1 Diabetes Management Training Program
Conditions studied
- type1diabetes — all drugs for type1diabetes →
- Adolescent Behavior — all drugs for Adolescent Behavior →
- Self Efficacy — all drugs for Self Efficacy →
Sponsor
Akdeniz University
Who can join
Adults 12 to 18, any sex, with type1diabetes or Adolescent Behavior. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Adolescence period; It is a transition period of rapid growth, development and maturation in biochemical, physical, social and spiritual terms, which lasts from the beginning of puberty to young adulthood. Adolescence is a predictable developmental transition period for the individual. They also encounter unpredictable situations (such as childhood illnesses). One of these conditions is Type 1 Diabetes Mellitus, which is the most common metabolic endocrine system disease in adolescents. Type 1 diabetes is an important health/disease transition in the life of a child and adolescent. Therefore, this study aimed to determine the effect of the "Adaptation to Adolescence and Type 1 Diabetes Management Training Programme", prepared in line with Meleis's Transition Theory, on the adolescent's developmental transition adaptation, self-efficacy for diabetes management and glycemic control.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06246279
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for type1diabetes
Currently open trials in the same condition.
- NCT06315127 — The CanDo (Canadian Donor Milk) Trial · NA · active not recruiting
- NCT05756829 — Type 1 Diabetes Virtual Self-management Education and Support · NA · recruiting
- NCT05421715 — Remote Digital Care Effects in Adolescents With Type 1 Diabetes · NA · recruiting
- NCT05454176 — Diabetes in African Youth · Phase 4 · recruiting
- NCT04593888 — Gluten Reduction and Risk of Celiac Disease · NA · active not recruiting
Other Akdeniz University trials
Trials by the same sponsor.
- NCT07581132 — Investigation of the Effect of Structured Energy Conservation Techniques Training on COPD Patients · NA · not yet recruiting
- NCT07469345 — Bruxism, Pelvic Pain, Erectile Dysfunction, and Anxiety in Young Adult Men · enrolling by invitation
- NCT07507279 — Technology-based Hand Rehabilitation in Older People · NA · not yet recruiting
- NCT07437924 — Bruxism and Pelvic Floor Dysfunction in Young Women · enrolling by invitation
- NCT07497308 — GDF-15 and Early Outcomes After LVAD Implantation · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06246279 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Akdeniz University
- Last refreshed: 31 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06246279.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing